AI Agents For Business: Best Practices for Building AI Agents
Key Takeaways:- Learn best practices for developing and deploying AI agents in production.
- Understand common development workflows and architectures used in enterprise agent systems.
- Discover common pitfalls and how to avoid them when bringing AI agents to life.
Description
As AI agents move from experimental tools to enterprise-ready solutions, the need for clear development best practices has never been greater. For managers and executives, understanding how agents are built—and how to successfully bring them into production—is key to turning innovation into real business value. Without a structured approach, organizations risk building agents that underdeliver or never make it past the pilot stage.
In this panel interview, John Ratzan, Senior Managing Director at Accenture, and Sam Khalil, CEO & Founder at a stealth AI agent startup, will host a discussion with industry experts on how to build and deploy AI agents that work in real business environments. You’ll learn about proven development workflows, architectural patterns that support scalability and adaptability, and how to align agent development with strategic objectives. The panel will also explore best practices for moving agents from prototype to production, as well as common pitfalls to avoid. This session is ideal for business leaders looking to operationalize AI agent solutions and maximize their impact.
Presenter Bio
John is a data and AI lead for financial services, providing consulting services to banking clients. He has twenty five years experience as a technology leader, and has worked extensively in business process and technology transformation. He is an expert in AI solutions for banking and payments systems.
Sam founded and runs a pharmaceutical AI agent startup. He has two decades experience as a healthcare leader, specializing in leveraging data and AI to drive progress in drug development and patient care. Previously, Sam was VP of Data & AI Platform at Novo Nordisk where he pioneered the FounData clinical research platform, and Chief Scientific Officer at Novartis for the data42 digital research and development platform.